The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 29, 2024
Filed:
Sep. 23, 2021
Applicant:
Paean Biotechnology Inc., Daejeon, KR;
Inventors:
Kyuboem Han, Daejeon, KR;
Youngjun Lee, Seoul, KR;
Assignee:
PAEAN BIOTECHNOLOGY INC., Daejeon, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 35/15 (2015.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); C12N 5/078 (2010.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 35/15 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C12N 5/0634 (2013.01); C12N 5/0646 (2013.01);
Abstract
An NK cells and PBMC, both having increased cytotoxicity are provided. Particularly, NK cells and PBMC which have exogenous mitochondria introduced thereinto potentiate the immune system of the human body to enhance a therapeutic effect on infectious diseases or cancer. Therefore, the NK cells and PBMC can be used in a composition for prevention or treatment of infectious diseases and cancer. Specially, autogenous NK cells and PBMC guarantee stability without the incurrence of an immune reaction, and thus would be expected to have high commercial activity.